Home » Topics » BioWorld Science

BioWorld Science
RSS

Abbott synthesizes a novel series of cyclic antifungal agents

Jan. 2, 1998

Commencement of phase II trials of LiquiVent for adult ARDS

Dec. 31, 1997

Raxar --new once-daily fluoroquinolone-- now available in U.S.

Dec. 31, 1997

Cambridge Antibody Technology: FY 1997 highlights

Dec. 31, 1997

FDA deems Provigil approvable

Dec. 31, 1997

Favorable phase III trial results reported for HER2 monoclonal antibody

Dec. 31, 1997

Banyu searches for potent, orally bioavailable FXa inhibitors

Dec. 31, 1997

FR-208419: a new dual CCK-A and CCK-B/gastrin receptor antagonist

Dec. 31, 1997

Potent and selective AMPA antagonist from Roche

Dec. 31, 1997

Cytogen updates stockholders

Dec. 31, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 9, 2026.
Hengrui discovers new Nav1.8 blockers
BioWorld Science
Researchers from Jiangsu Hengrui Pharmaceuticals Co. Ltd. and Shanghai Hengrui Pharmaceutical Co. Ltd. have patented new sodium channel protein type 10 subunit α...
Hematopoietic stem cell research points to leukemia’s early roots
BioWorld Science
Hematopoietic stem cell (HSC) research over the past century has shown that leukemia may be driven by an invisible hand of inflammation. The bone marrow and...
Infinimmune presents preclinical data on anti-IL-22 antibody for atopic dermatitis
BioWorld Science
Infinimmune Inc. has recently presented results at the annual American Academy of Dermatology conference regarding their anti-IL-22 antibody IFX-101 for the...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 7, 2026